Cairo – Mubasher: Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) registered a 119% year-on-year (YoY) surge in its net profits, logging EGP 68.16 million in the first nine months of 2020, compared to EGP 31.14 million.

Revenues grew to EGP 672.858 million in the January-September period from EGP 619.459 million in the prior-year period, Rameda said in a bourse disclosure on Tuesday.

As for standalone business, the company achieved net profits of EGP 69.19 million in the first nine months of the year, up from EGP 31.97 million in the same period in 2019.

During the first half (H1) of 2020, Rameda posted net profits of EGP 43.47 million, compared to EGP 20.6 million in H1-19.